Advertisement

Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and 18F-FDG using a combined PET/MR scanner

      Highlights

      • Combined PET/MR scanner can be used to assess plaque inflammation.
      • Correlation between SUV or R2* and macrophages density were good.
      • FDG-PET seems to be more sensitive than USPIO enhanced MRI.

      Abstract

      Purpose

      The aim of this study was to compare the ability of 18F-FDG PET and iron contrast-enhanced MRI with a novel USPIO (P904) to assess change in plaque inflammation induced by atorvastatin and dietary change in a rabbit model of atherosclerosis using a combined PET/MR scanner.

      Materials and methods

      Atherosclerotic rabbits underwent USPIO-enhanced MRI and 18F-FDG PET in PET/MR hybrid system at baseline and were then randomly divided into a progression group (high cholesterol diet) and a regression group (chow diet and atorvastatin). Each group was scanned again 6 months after baseline imaging. R2* (i.e. 1/T2*) values were calculated pre/post P904 injection. 18F-FDG PET data were analyzed by averaging the mean Standard Uptake Value (SUVmean) over the abdominal aorta. The in vivo imaging was then correlated with matched histological sections stained for macrophages.

      Results

      18F-FDG PET showed strong FDG uptake in the abdominal aorta and P904 injection revealed an increase in R2* values in the aortic wall at baseline. At 6 months, SUVmean values measured in the regression group showed a significant decrease from baseline (p = 0.015). In comparison, progression group values remained constant (p = 0.681). R2* values showed a similar decreasing trend in the regression group suggesting less USPIO uptake in the aortic wall. Correlations between SUVmean or Change in R2* value and macrophages density (RAM-11 staining) were good (R2 = 0.778 and 0.707 respectively).

      Conclusion

      This experimental study confirms the possibility to combine two functional imaging modalities to assess changes in the inflammation of atherosclerotic plaques. 18F-FDG-PET seems to be more sensitive than USPIO P904 to detect early changes in plaque inflammation.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ross R.
        Atherosclerosis is an inflammatory disease.
        Am Heart J. 1999; 138: S419-S420
        • Crisby M.
        • Nordin-Fredriksson G.
        • Shah P.K.
        • Yano J.
        • Zhu J.
        • Nilsson J.
        Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization.
        Circulation. 2001; 103: 926-933
        • Sukhova G.K.
        • Williams J.K.
        • Libby P.
        Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol.
        Arterioscler Thromb Vasc Biol. 2002; 22: 1452-1458
        • Rudd J.H.
        • Warburton E.A.
        • Fryer T.D.
        • et al.
        Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.
        Circulation. 2002; 105: 2708-2711
        • Tang T.Y.
        • Muller K.H.
        • Graves M.J.
        • et al.
        Iron oxide particles for atheroma imaging.
        Arterioscler Thromb Vasc Biol. 2009; 29: 1001-1008
        • Sigovan M.
        • Boussel L.
        • Sulaiman A.
        • et al.
        Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model.
        Radiology. 2009; 252: 401-409
        • Tang T.Y.
        • Howarth S.P.
        • Miller S.R.
        • et al.
        The ATHEROMA (atorvastatin therapy: effects on reduction of macrophage activity) study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease.
        J Am Coll Cardiol. 2009; 53: 2039-2050
        • Tawakol A.
        • Fayad Z.A.
        • Mogg R.
        • et al.
        High dose statin results in a further reduction in atherosclerotic inflammation compared with low dose statin: results of a Multi-Center PET-CT study.
        Circulation. 2011; 124 (Abstract 18242)
        • Kooi M.E.
        • Cappendijk V.C.
        • Cleutjens K.B.
        • et al.
        Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging.
        Circulation. 2003; 107: 2453-2458
        • Tang T.Y.
        • Howarth S.P.
        • Miller S.R.
        • et al.
        Correlation of carotid atheromatous plaque inflammation using USPIO-enhanced MR imaging with degree of luminal stenosis.
        Stroke. 2008; 39: 2144-2147
        • Trivedi R.A.
        • Mallawarachi C.
        • King-Im J.M.U.
        • et al.
        Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages.
        Arterioscler Thromb Vasc Biol. 2006; 26: 1601-1606
        • te Boekhorst B.C.
        • Bovens S.M.
        • Nederhoff M.G.
        • et al.
        Negative MR contrast caused by USPIO uptake in lymph nodes may lead to false positive observations with in vivo visualization of murine atherosclerotic plaque.
        Atherosclerosis. 2010; 210: 122-129
        • Briley-Saebo K.C.
        • Mani V.
        • Hyafil F.
        • Cornily J.C.
        • Fayad Z.A.
        Fractionated Feridex and positive contrast: in vivo MR imaging of atherosclerosis.
        Magn Reson Med. 2008; 59: 721-730
        • Sigovan M.
        • Bessaad A.
        • Alsaid H.
        • et al.
        Assessment of age modulated vascular inflammation in ApoE−/− mice by USPIO-enhanced magnetic resonance imaging.
        Invest Radiol. 2010; 45: 702-707
        • Kuhlpeter R.
        • Dahnke H.
        • Matuszewski L.
        • et al.
        R2 and R2* mapping for sensing cell-bound superparamagnetic nanoparticles: in vitro and murine in vivo testing.
        Radiology. 2007; 245: 449-457
        • Zhou G.
        • Ge S.
        • Liu D.
        • et al.
        Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway.
        Cardiology. 2010; 115: 221-228
        • Worthley S.G.
        • Zhang Z.Y.
        • Machac J.
        • et al.
        In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis.
        Int J Cardiovasc Imaging. 2009; 25: 251-257
        • Vucic E.
        • Dickson S.D.
        • Calcagno C.
        • et al.
        Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging.
        JACC Cardiovasc Imaging. 2011; 4: 1100-1109
        • Wu Y.W.
        • Kao H.L.
        • Huang C.L.
        • et al.
        The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers.
        Eur J Nucl Med Mol Imaging. 2012; 39: 399-407
        • Rudd J.H.
        • Myers K.S.
        • Bansilal S.
        • et al.
        Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.
        J Nucl Med. 2008; 49: 871-878
        • Izquierdo-Garcia D.
        • Davies J.R.
        • Graves M.J.
        • et al.
        Comparison of methods for magnetic resonance-guided [18-F] fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods.
        Stroke. 2009; 40: 86-93
        • Lobatto M.E.
        • Calcagno C.
        • Metselaar J.M.
        • et al.
        Imaging the efficacy of anti-inflammatory liposomes in a rabbit model of atherosclerosis by non-invasive imaging.
        Methods Enzymol. 2012; 508: 211-228
        • Derlin T.
        • Habermann C.R.
        • Hahne J.D.
        • et al.
        Quantification of [18F]-FDG uptake in atherosclerotic plaque: impact of renal function.
        Ann Nucl Med. 2011; 25: 586-591
        • Tahara N.
        • Kai H.
        • Ishibashi M.
        • et al.
        Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.
        J Am Coll Cardiol. 2006; 48: 1825-1831
        • Puato M.
        • Faggin E.
        • Rattazzi M.
        • et al.
        Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy.
        Stroke. 2010; 41: 1163-1168
        • Riedmüller K.
        • Metz S.
        • Bonaterra G.A.
        • et al.
        Cholesterol diet and effect of long-term withdrawal on plaque development and composition in the thoracic aorta of New Zealand white rabbits.
        Atherosclerosis. 2010; 210: 407-413
        • Folco E.J.
        • Sheikine Y.
        • Rocha V.Z.
        • et al.
        Hypoxia but not inflammation augments glucose uptake in human macrophages: implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography.
        J Am Coll Cardiol. 2011; 58: 603-614
        • Calcagno C.
        • Cornily J.C.
        • Hyafil F.
        • et al.
        Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET.
        Arterioscler Thromb Vasc Biol. 2008; 28: 1311-1317
        • Amirbekian V.
        • Lipinski M.J.
        • Briley-Saebo K.C.
        • et al.
        Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI.
        Proc Natl Acad Sci U S A. 2007; 104: 961-966
        • Briley-Saebo K.C.
        • Cho Y.S.
        • Shaw P.X.
        • et al.
        Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes.
        J Am Coll Cardiol. 2011; 57: 337-347
        • Ouimet T.
        • Lancelot E.
        • Hyafil F.
        • et al.
        Molecular and cellular targets of the MRI contrast agent p947 for atherosclerosis imaging.
        Mol Pharm. 2012; 9: 850-861
        • Hyafil F.
        • Vucic E.
        • Cornily J.C.
        • et al.
        Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metalloproteinases.
        Eur Heart J. 2011; 32: 1561-1571